News
Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...
Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...
Pope Leo XIV vowed to take “every effort” Wednesday to work for peace in the Middle East and Ukraine and to actively promote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results